Glp-1 pharmaceutical compositions
OwnerZheng Xin Dong, Roland Cherif-Cheikh +4inventors
InventorsZheng Xin Dong, Roland Cherif-Cheikh, Jose-Antonio Cordero-Rigol, Resurreccion Alloza Miravete, Frederic Lacombe, Maria Dolores Tobalina Maestre
Life of this patent
Estimating the term…
Abstract
The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues.
Claims17
A pharmaceutical composition comprising an analog of GLP-1 prepared with a pharmaceutically acceptable salt of said analog or a mixture of the salt of said analog and the analog, thereby providing a molar ratio of analog salt to peptide analog in said pharmaceutical composition, wherein the molar ratio can be adjusted to modulate the solubility, the pH, and release effect on in vivo release profile of the peptide in said pharmaceutical composition.
Dependencies are inferred from the claim text.